BARRIERS TO BENEVOLENCE: EXPLORING THE REASONS FOR BLOOD DONOR DEFERRALS IN THE SOUTHERN ODISHA REGION
Main Article Content
Keywords
Voluntary Blood Donor, Predonation, Postdonation, Temporary Deferred, Permanently Deferred.
Abstract
Background
The blood donor selection is vital for the safety of donors and recipients as well as for maintaining an adequate blood supply. A detailed evaluation of various causes of blood donor deferral may help medical personnel limit the barriers that disrupt blood donation.
Aims & objective
To analyze various causes of blood donor deferral among blood donors. The primary objective is to estimate the various reasons for donor deferral during the screening process before and after blood donation.
Method
This is a prospective observational study for six months, from July 2024 to December 2024, at the Odisha Blood Centre, MKCG Medical College and Hospital (MKCG MCH), Berhampur, Odisha. This study includes all deferred blood donors, both predonation deferral during the screening process and post-donation deferral during the specified period.
Results
During the study period, 20708 blood donors were screened. 20267 donors were accepted for blood donation, and 441 no. of donors were deferred on predonation screening, and 620 no. of donors were deferred on post donation from the selected blood donors.Among 441 predonation deferrals, 411(93.2%) were temporary deferrals and 30(6.8%) were permanent deferrals. Deferred due to low hemoglobin108 (26.27%), Tattoos 65 (15.81%), and 50 (12.16%) due to underweight were the leading causes for temporary predonation deferral.30 donors (6.4%) were permanently deferred; the most common cause was endocrine disorders, 17(3.85%), predominantly due to thyroid dysfunction, 9(30%), and uncontrolled diabetes mellitus, 8(26.66%) during predonation screening. In postdonation deferral 620 donors (3.05%) were deferred due to detection of transfusion-transmissible infections (TTIs) as follows: HBV 392 (1.93%), Syphilis (VDRL) 173 (0.85%), HIV 32 (0.15%), HCV 20 (0.09%), were deferred permanently and Malaria parasite 3 (0.01%) were deferred for a temporary period.
Conclusion
To significantly improve donor eligibility and retention rates, we must decisively tackle modifiable deferral causes-especially low hemoglobin levels, underweight status, and tattoo-related exclusions. By investing in targeted pre-donation education, focused interventions, and enhanced community outreach, we can create a more inclusive and effective donor environment that benefits everyone involved.
References
[2] AlNouri AK, Maghrabi LA, Hamdi SS, et al. Analysis of the most common causes of blood donor deferral in northern Jeddah: a single-center study. J Blood Med 2019;10:47-51.
[3] World Health Organization. Blood donor selection: guidelines on assessing donor suitability for blood donation. Geneva: World Health Organization 2012.
[4] Vimal M, Sowmya S, Nishanthi et al. Evaluation of blood donor deferral causes: a retrospective study from South India. Annals of Pathology and Laboratory Medicine 2016;3:606-11.
[5] Rehman S, Arif HS, Mehdi G, et al. The evaluation of blood donor deferral causes: a tertiary care centre based study. Journal of Blood Disorders and Transfusion 2012;3(5):1-3.
[6] Jethani N, Goyal V, Pachori G, et al. Analysis of pre-donation blood donor deferral characteristics in Ajmer (Rajasthan) region. International Journal of Medical Science and Public Health 2016;5(5):2435-42.
[7] Sahani N, Bajaj S, Tirkey R, et al. Pre-donation deferral of blood donors: a retrospective analysis in a tertiary care hospital. International Journal of Science and Research 2019;8(11):1293-6.
[8] Sundar P, Sangeetha SK, Seema DM, et al. Pre-donation deferral of blood donors in South Indian set-up: An analysis. Asian J Transfus Sci 2010;4(2):112-5.
[9] Chaudhary RK, Gupta D, Gupta RK. Analysis of donor-deferral pattern in a voluntary blood donor population. Transfus Med 1995;5(3):209-12.
[10] WHO. Towards 100% voluntary blood donation a global framework for action. 2010 [cited 18 2]; 103]. https://apps.who.int/iris/handle/10665/44359.
[11] Ministry of Health and Family Welfare. Drugs and Cosmetics (Second Amendment) Rules, 2020. GSR 166(E). New Delhi (India); March. 2020: p. 15. Available from: https://thehealthmaster.com/wp-content/uploads/2020/03/GSR-166-E-11-03-20-Blood-Bank-Blood-Centre.pdf.
[12] Lamba DS, Sachdev S, Hans R, et al. Review of blood donor deferral with emphasis on donor and patient safety. Transfus Clin Biol. 2023;30(1):56-62.
[13] Sharma. Analysis of rates and reasons of whole blood donor deferral at a tertiary care hospital. Journal of Medical Science and Clinical Research 2024;12:1-7.
[14] Sharma SK, Das P, Deka M. Analysis of Blood Donor Deferral Patterns and their Underlying Causes in a Multispeciality Hospital in Guwahati, Assam. International Journal of Science and Research (IJSR) 2025;14(4):363-6.
[15] Duvvuri PSR, Teendra B, Pola N, et al. Analysis of donor deferrals causes in blood donation center-tertiary care hospital study. Int J Res Orthop 2024;10:1266-9.
[16] Shah R, Tulsiani S, Harimoorthy V, et al. Asian J Analysis of efforts to maintain safe donor in main donor pool after completion of temporary deferral period. Transfus Sci. 2013;7:63-67.
[17] Asirvatham ES, Mammen JJ, Lakshman J, et al. Assessment of Performance of Blood Banks in India: A National Level Cross Sectional Study. Indian J Hematol Blood Transfus 2021;37(4):640-7.
[18] Narayanan DE, Rajan AR, Bindu V. Gender distribution and reasons for donor deferral in blood donors at a tertiary healthcare centre, Kerala, India: a cross-sectional study. National J Lab Med 2023;12:58-61.
[19] Kandasamy D, Shastry S, Chenna D, et al. Blood donor deferral analysis in relation to the screening process: a single-center study from southern India with emphasis on high hemoglobin prevalence. J Blood Med 2020;11:327-34.
[20] Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci 2010;4(2):116-22.
[21] Kumari S, Arya D, Mahawar NL, et al. Prevalence and pattern of anemia among persons reported for blood donation at a tertiary care center in western part of Rajasthan. Int. J. Med. Sci. Public Heal 2016;5:1256-9.
[22] Nishioka S, Gyorkos TW. Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis 2001;5(1):27-34.
[23] Quee F, O'Brien SF, Prinsze F, et al. Whole blood donor return rates after deferral for tattooing or body piercing-survey across blood donation services: The BEST collaborative study. Vox Sang 2022;117:1085 9.
[24] Kujur D, Tiwari D, Bagde D, et al. Assessment of blood donor selection and deferral pattern in a tertiary care hospital in Central India 2020;6:83-8.
[25] Harjot K, Mannan R, Mridu M, et al. Blood donor deferral analysis: a tertiary care centre experience. 2022
[26] Arjunan C, Basavarajegowda A. Is tattooing associated with increased seroprevalence of transfusion-transmitted infections among blood donors: a single-center study from Southeastern India. Asian J Transfus Sci 2024;18(1):85-90.
[27] Bahadur S, Jain S, Goel RK, et al. Analysis of blood donor deferral characteristics in Delhi, India. Southeast Asian J Trop Med Public Health 2009;40(5):1087-91.
[28] World Health Organization. Blood donor selection: guidelines on assessing donor suitability for blood donation. Geneva: WHO 2012.
[29] Chaurasiya P, Tyagi MSK, Singh S, et al. Analysis of blood donor deferral pattern in a tertiary care hospital in Northern India. Santosh University Journal of Health Sciences 2024;10:220–4.
[30] Ahmed SN, Gogoi B, Rahman S, et al. Blood donor deferral pattern as a key tool for safe blood transfusion practice: a retrospective study from north east India. International Journal of Scientific Research 2022;11(12):74-6.
[31] Gupta P, Bhushan R, Iyengar S. Evaluation of blood donor deferral pattern in central India: a study in a tertiary care centre blood bank. International Journal of Scientific Research, 2023;12(7):76-8.
[32] Thakur SK, Singh S, Negi DK, et al. Prevalence of TTI among Indian blood donors. Bioinformation 2023;19(5):582-9.
[33] Joshi S, Khare V, Pant KC, et al. A Study on transfusion transmitted infections amongst blood donors in the blood bank at tertiary care center. International Journal of Current Pharmaceutical Review and Research 2025;17(4):405-10.
[34] Mahapatra S, Ray GK, Panigrahi R, et al. The incidence and spectrum of transfusion transmitted infections among the blood donors. Int J Res Med Sci 2018;6(3):904-7.
[35] Mukherjee S, Agarwal SK, Tiwari S. Seroprevalence of transfusion transmitted infections among blood donors attending a tertiary care hospital of Western Odisha. J Evolution Med Dent Sci 2020;9:483-7.
[36] National Blood Transfusion Council (NBTC). Guidelines for Blood Donor Selection and Blood Donor Deferral. New Delhi: Ministry of Health & Family Welfare 2017.
[37] Rajeswari T, Sivaramakrishnan A, Meenakshisundaram K. Evaluation of blood donor pre-donation deferral causes in ESIC Medical College Hospital, Chennai, Tamilnadu. Indian Journal of Pathology and Oncology 2020;7:571-5.
[38] Bassirajni B, Singal P, Kaur L, et al. Evaluation of whole blood donor deferrals in a North Indian tertiary center. Asian J Transfus Sci 2024;17(1).